Cellosaurus HyCyte B-CPAP stable cell line for hSLC5A5 overexpression (CVCL_F4QG)
| Cell line name | HyCyte B-CPAP stable cell line for hSLC5A5 overexpression |
|---|---|
| Synonyms | B-CPAP stable cell line for hSLC5A5 overexpression |
| Accession | CVCL_F4QG |
| Resource Identification Initiative | To cite this cell line use: HyCyte B-CPAP stable cell line for hSLC5A5 overexpression (RRID:CVCL_F4QG) |
| Comments | Population: Caucasian. Characteristics: Transduced with pLV[Exp]-CMV>hSLC5A5[NM_000453.3]-EF1A>GFP:T2A:Puro-WPRE. Doubling time: 24-36 hours (Hysigen=CGSC-M31151). Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; EGFP. Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5. Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. |
| Sequence variations |
|
| Disease | Poorly differentiated thyroid gland carcinoma (NCIt: C6040) Thyroid carcinoma (ORDO: Orphanet_100088) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0153 (B-CPAP) |
| Sex of cell | Female |
| Age at sampling | 76Y |
| Category | Cancer cell line |
| Cross-references | |
| Cell line collections (Providers) | Hysigen; CGSC-M31151 |
| Entry history | |
| Entry creation | 25-Jun-2026 |
| Last entry update | 25-Jun-2026 |
| Version number | 1 |